The Medicinal and Synthetic Chemistry Core (ChemCore) is a shared resource facility dedicated to providing chemistry services for advancing drug discovery and chemical biology research. The facility serves investigators ofthe Robert H. Lurie Comprehensive Cancer Center (RHLCCC), Northwestern University, and external organizations by providing a range of customized services in three primary areas: Cheminformatics, Medicinal and synthetic chemistry, and Compound purification. The cheminformatics service provides computational chemistry, molecular modeling, and computer-aided drug design. These services provide investigators with unique insights into fundamental processes of cancer biology and allow efficient access to powerful platforms to advance early stage drug discovery efforts prior to committing larger resources. The medicinal chemistry service provides researchers with access to high-level resources for the custom synthesis of molecular probe and tools compounds, hit-to-lead chemistry, lead optimization medicinal chemistry, and consulting on drug discovery projects. This service is staffed by professional medicinal chemists who help enable translational research based on the basic research of RHLCCC members. Finally, ChemCore also provides comprehensive instrumentation and expertise to purify and reformat small molecules. Purification services include a full-service custom dual-purpose analytical-to preparative mass-directed HPLC (A2Prep LCMS) and self-service analytical and preparative HPLCs, each equipped with UV and ELS detection. This equipment helps RHLCCC members carry out small molecule chemical biology and drug discovery research much more rapidly. ChemCore works closely with the affiliated RHLCCC High Throughput Analysis Laboratory (HTAL) and Developmental Therapeutics Core (DTC) facilities, which carry out high-throughput screening, in vivo testing, and pre-IND development. Together with these cores, ChemCore provides RHLCCC members and their collaborators with a pipeline to translate basic discoveries into the clinic.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Center Core Grants (P30)
Project #
Application #
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Northwestern University at Chicago
United States
Zip Code
Yang, Ruiguo; LemaƮtre, Vincent; Huang, Changjin et al. (2018) Monoclonal Cell Line Generation and CRISPR/Cas9 Manipulation via Single-Cell Electroporation. Small 14:e1702495
Buglak, Nicholas E; Jiang, Wulin; Bahnson, Edward S M (2018) Cinnamic aldehyde inhibits vascular smooth muscle cell proliferation and neointimal hyperplasia in Zucker Diabetic Fatty rats. Redox Biol 19:166-178
Takahashi, Satoe; Sun, Willy; Zhou, Yingjie et al. (2018) Prestin Contributes to Membrane Compartmentalization and Is Required for Normal Innervation of Outer Hair Cells. Front Cell Neurosci 12:211
Zheng, Jianbin; Chen, Long; Skinner, Owen S et al. (2018) ?-Glucocerebrosidase Modulators Promote Dimerization of ?-Glucocerebrosidase and Reveal an Allosteric Binding Site. J Am Chem Soc 140:5914-5924
Kenney, Grace E; Dassama, Laura M K; Pandelia, Maria-Eirini et al. (2018) The biosynthesis of methanobactin. Science 359:1411-1416
Joyce, Brian T; Zheng, Yinan; Zhang, Zhou et al. (2018) miRNA-Processing Gene Methylation and Cancer Risk. Cancer Epidemiol Biomarkers Prev 27:550-557
Chu, Lan H; Indramohan, Mohanalaxmi; Ratsimandresy, Rojo A et al. (2018) The oxidized phospholipid oxPAPC protects from septic shock by targeting the non-canonical inflammasome in macrophages. Nat Commun 9:996
Symes, Yael R; Barrington, Clare; Austin, Jane et al. (2018) Advice to patients undergoing stem cell transplant: Content analysis of survivor peer support narratives. J Health Psychol 23:818-828
Lewis, Phillip L; Green, Richard M; Shah, Ramille N (2018) 3D-printed gelatin scaffolds of differing pore geometry modulate hepatocyte function and gene expression. Acta Biomater 69:63-70
Ugolkov, Andrey V; Bondarenko, Gennadiy I; Dubrovskyi, Oleksii et al. (2018) 9-ING-41, a small-molecule glycogen synthase kinase-3 inhibitor, is active in neuroblastoma. Anticancer Drugs 29:717-724

Showing the most recent 10 out of 1972 publications